Adagio Medical’s vCLAS Cryoablation System Earns FDA Breakthrough Status Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a pioneer in catheter-based technologies for treating cardiac arrhythmias, has announced that its vCLAS™ Cryoablation System has received Breakthrough Device designation from the U.S. Food…
Paragon Denali Introduces Nabla for Ambient Listening in Rural Hospitals Altera Digital Health, a global leader in health IT solutions, has announced the general availability of Nabla’s ambient artificial intelligence (AI) assistant for clinicians using its Paragon® Denali electronic health…
Agilent Earns IVDR Certification for Gastric Cancer Companion Diagnostic Agilent Technologies Inc. (NYSE: A) announced that its PD-L1 IHC 22C3 pharmDx assay (Code SK006) has received European In Vitro Diagnostic Regulation (IVDR) certification for use as a Companion Diagnostic (CDx)…
Artedrone’s SASHA Robot Shows Autonomous Stroke Clot Removal in Preclinical Studies Artedrone, a medical technology company backed by Truffle Capital, has announced promising preclinical results for its innovative SASHA micro-robot—an autonomous device designed to perform mechanical thrombectomy procedures for patients…
Bruker Acquires Majority Stake in RECIPE for Drug Monitoring Assays Bruker Corporation (NASDAQ: BRKR) has announced a strategic majority investment in RECIPE Chemicals + Instruments GmbH, a well-established provider of clinical diagnostic kits for mass spectrometry-based assays. Based in Munich,…
Octave’s MSDA Test Offers Actionable Insights for MS Care Octave Bioscience, a precision care company focused on multiple sclerosis (MS) and other neurodegenerative diseases, has announced the publication of a real-world clinical utility study in Multiple Sclerosis Journal – Experimental,…
Bayer Announces $44M Investment in Myerstown Manufacturing Facility Bayer celebrated a major milestone with the grand opening of a 70,000-square-foot expansion at its Myerstown, Pennsylvania manufacturing site, marking the completion of a $44 million investment announced in 2022. This state-of-the-art…
ACIP Expands Pfizer’s RSV Vaccine Recommendation to At-Risk Adults 50–59 Pfizer Inc. (NYSE: PFE) announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has voted to expand its recommendation for the use…
Cigna and Business Roundtable Host Workforce Mental Health Summit Business Roundtable and The Cigna Group convened senior executives and community leaders last week in the Bay Area for a Workforce Mental Health Summit. The event was part of the Business…
GC Therapeutics Adds Industry Veterans Kai-Hsin Chang and Azadeh Golipour to Leadership Team GC Therapeutics (GCTx), a trailblazing biotechnology company advancing innovative induced pluripotent stem cell (iPSC)-based therapies, today announced the expansion of its leadership team with the appointments of…
FDA Clears HeartFocus, AI-Powered Cardiac Imaging Software DESKi has announced that its AI-powered heart imaging software, HeartFocus, has received FDA clearance. Designed to simplify cardiac exams, HeartFocus enables any healthcare professional—even those with minimal experience—to perform clinical-quality heart scans using…
n-Lorem Foundation Marks 5 Years of Hope for Nano-rare Patients The n-Lorem Foundation, a pioneering nonprofit organization, is celebrating its fifth anniversary of delivering life-changing personalized experimental treatments to nano-rare patients—completely free of charge, for life. Founded with a bold…